Answers are grounded in this paper and cite their sources.
Summary This paper first describes the difficulties in providing the required sample sizes for clinical trials that guarantee type 1 and type 2 error control. The required sample sizes obviously depend on the test employed, and in this study we use the so‐called E ‐test, which is known to have extremely favourable size properties and higher power than alternatives. To compute exact powers for this test in real time is not currently feasible, so a corpus of pre‐computed exact powers (and sizes) was created, covering sample sizes up to 500. When there are no solutions within the corpus, a novel extrapolation technique is used. Exact size can be computed after the sample sizes have been extracted; however, for the E ‐test the exact size is virtually always very close to the nominal target. All the code has been converted into an R‐package , which is available on CRAN and illustrated.
No takes yet. Share an insight, caveat, or question.
Chris J. Lloyd (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: